Lobbying client
DURATA THERAPEUTICS, INC.
Pharmaceutical company focused on the development of solutions for infectious diseases
Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$44,000
Filings
9 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination Amendment 3rd Quarter 2014
|
THE CONAFAY GROUP, LLC | $24,000 reported |
|
2nd Quarter - Termination 2nd Quarter 2014
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
3rd Quarter - Reportreplaced 3rd Quarter 2014
|
THE CONAFAY GROUP, LLC | $24,000 reported |
|
2nd Quarter - Amendmentreplaced 2nd Quarter 2014
|
THE CONAFAY GROUP, LLC | $24,000 reported |
|
3rd Quarter - Termination Amendmentreplaced 3rd Quarter 2014
|
THE CONAFAY GROUP, LLC | $24,000 reported |
|
2nd Quarter - Amendmentreplaced 2nd Quarter 2014
|
THE CONAFAY GROUP, LLC | $24,000 reported |
|
2nd Quarter - Report (No Activity)replaced 2nd Quarter 2014
|
THE CONAFAY GROUP, LLC | — reported |
|
3rd Quarter - Termination (No Activity)replaced 3rd Quarter 2014
|
THE CONAFAY GROUP, LLC | — reported |
|
Registration 2nd Quarter 2014
|
THE CONAFAY GROUP, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE CONAFAY GROUP, LLC | 2 | $44,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medicare/Medicaid | MMM | 3 |
| Medical/Disease Research/Clinical Labs | MED | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.